Enhancement of the thrombolytic potency of plasminogen activators by conjugation with clot-specific monoclonal antibodies.
Dewerchin
M
M
Center for Thrombosis and Vascular Research, University of Leuven, Belgium.
Collen
D
D
D000911:Antibodies, Monoclonal / Q000737:chemistry; D001792:Blood Platelets / Q000276:immunology; D004337:Drug Carriers; D005337:Fibrin / Q000276:immunology; D006801:Humans; D010960:Plasminogen Activators / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D015912:Thrombolytic Therapy
D000911:Antibodies, Monoclonal; D004337:Drug Carriers; D005337:Fibrin; D010960:Plasminogen Activators